Statewide School-located Influenza Vaccination Program for Children 5–13 Years of Age, Hawaii, USA
Open Access
- 1 February 2010
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 16 (2) , 244-250
- https://doi.org/10.3201/eid1602.091375
Abstract
New guidance recommends annual influenza vaccination for all children 5–18 years of age in the United States. During 2007–2008, Hawaii offered inactivated and live attenuated influenza vaccine at school-located clinics for grades kindergarten through 8. Most (90%) public and private schools participated, and 622 clinics were conducted at 340 schools. Of 132,775 children 5–13 years of age, 60,760 (46%) were vaccinated. The proportion vaccinated peaked at 54% for those 6 years of age and declined for older cohorts. More than 90% of schoolchildren transited the clinic in <10 minutes. A total of 16,920 staff-hours were expended; estimated cost per dose administered was $27 and included vaccine purchase and administration, health staffing resources, printing costs, data management, and promotion. This program demonstrates the feasibility of conducting mass school-located influenza vaccination programs in public and private schools statewide, as might be indicated to respond to pandemic influenza.Keywords
This publication has 23 references indexed in Scilit:
- Non-Traditional Settings for Influenza Vaccination of AdultsPharmacoEconomics, 2008
- Mass Distribution of Free, Intranasally Administered Influenza Vaccine in a Public School SystemPediatrics, 2007
- The annual impact of seasonal influenza in the US: Measuring disease burden and costsVaccine, 2007
- Effectiveness of School-Based Influenza VaccinationNew England Journal of Medicine, 2006
- Mitigation strategies for pandemic influenza in the United StatesProceedings of the National Academy of Sciences, 2006
- Universal vaccination of children against influenza: Are there indirect benefits to the community?: A systematic review of the evidenceVaccine, 2006
- Community Studies for Vaccinating Schoolchildren Against InfluenzaScience, 2006
- Live Attenuated Influenza Vaccine, Trivalent, Is Safe in Healthy Children 18 Months to 4 Years, 5 to 9 Years, and 10 to 18 Years of Age in a Community-Based, Nonrandomized, Open-Label TrialPediatrics, 2005
- Illness Among Schoolchildren During Influenza SeasonArchives of Pediatrics & Adolescent Medicine, 2002
- Modification of an Outbreak of Influenza in Tecumseh, Michigan by Vaccination of SchoolchildrenThe Journal of Infectious Diseases, 1970